Estela Rodriguez, Associate Director, Community Outreach of Thoracic Oncology at Sylvester Comprehensive Cancer Center , shared a post on X:
“If we move our best therapies upfront, what are the 2nd line options for EGFR lung cancer beyond platinum-chemo?
- amivantamab+chemo
- ivonescimab+chemo
- ADCs: DatoDxd, PatritumabDxd.”
More posts featuring TexasLung25.
